<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<oembed>
  <author_name>ynakamurachicago</author_name>
  <author_url>https://blog.hatena.ne.jp/ynakamurachicago/</author_url>
  <blog_title>Yusuke Nakamura「これでいいのか日本の医療」 ”What’s up?&quot;</blog_title>
  <blog_url>https://yusukenakamura.hatenablog.com/</blog_url>
  <categories>
  </categories>
  <description>The 22 October issue of Nature featured a paper titled “SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade” and a summary article titled “Tumours might be sensitized to immune therapy by COVID mRNA vaccines.” Because Nature uses British rather than American English, “tumour” is…</description>
  <height>190</height>
  <html>&lt;iframe src=&quot;https://hatenablog-parts.com/embed?url=https%3A%2F%2Fyusukenakamura.hatenablog.com%2Fentry%2F2025%2F11%2F14%2F222942&quot; title=&quot;Do COVID-19 mRNA vaccines enhance the efficacy of cancer immune-checkpoint antibodies? - Yusuke Nakamura「これでいいのか日本の医療」 ”What’s up?&amp;quot;&quot; class=&quot;embed-card embed-blogcard&quot; scrolling=&quot;no&quot; frameborder=&quot;0&quot; style=&quot;display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;&quot;&gt;&lt;/iframe&gt;</html>
  <image_url>https://cdn-ak.f.st-hatena.com/images/fotolife/y/ynakamurachicago/20251114/20251114221709.png</image_url>
  <provider_name>Hatena Blog</provider_name>
  <provider_url>https://hatena.blog</provider_url>
  <published>2025-11-14 22:29:42</published>
  <title>Do COVID-19 mRNA vaccines enhance the efficacy of cancer immune-checkpoint antibodies?</title>
  <type>rich</type>
  <url>https://yusukenakamura.hatenablog.com/entry/2025/11/14/222942</url>
  <version>1.0</version>
  <width>100%</width>
</oembed>
